Todt Blair Williams's Form 4 filing
Elevance Health, Inc. (ELV) · filed Dec 15, 2023
- Accession no.
- 0001156039-23-000124
- Filed
- Dec 15, 2023
- Trade date
- Dec 14, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.66M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Todt Blair WilliamsCIK 0001456430 | Officer (EVP, CLO & CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common Stock | MOption exerciseAcquired | +5,492 | $311.48 | +$1,710,648.16 | 18,004 | Direct | |
| Dec 14, 2023 | Common Stock | SSaleDisposed | −5,492 | $484.02 | −$2,658,237.84 | 12,512 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common Stock | MOption exerciseDisposed | −5,492 | $0.00 | $0 | 2,746 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.